ARCHIVES

In Brief: FDA approves Three-Hour Taxol Infusion; Foti Elected President Of NCCR; Luce Retires

This article is from The Cancer Letter archive.

Vol. 20 No. 34 | September 9, 1994

Download PDF Visit The Full Archive

Related Articles

Pepper’s Legacy Included NCI, Other Biomedical Research

June 9, 1989

Cancer Policy; Cost Containment Impedes Research, Cancer Panel Finds

October 17, 1997

DCPC To Merge Two Programs, Reorganizes Chemoprevention

November 4, 1994

Horvitz Wins BMS Award In Neuroscience; Group Room To Discuss Congressional Issues.

February 22, 2002

BMS Agent Yervoy Received FDA Approval for Metastatic Melanoma

March 25, 2011

ACS Creates $1 Billion Nationwide Organization, Taking Fiduciary Control From 12 Divisions

November 18, 2011